首页> 外文期刊>Journal of Medical Virology >Human cytomegalovirus (HCMV)‐specific T cell but not neutralizing or IgG binding antibody responses to glycoprotein complexes gB, gHgLgO, and pUL128L correlate with protection against high HCMV viral load reactivation in solid‐organ transplant recipients
【24h】

Human cytomegalovirus (HCMV)‐specific T cell but not neutralizing or IgG binding antibody responses to glycoprotein complexes gB, gHgLgO, and pUL128L correlate with protection against high HCMV viral load reactivation in solid‐organ transplant recipients

机译:人巨细胞病毒(HCMV)特异性T细胞,但未中和或未中和对糖蛋白复合物GB,GHGLGO和PUL128L的反应与固体器官移植受体中的高HCMV病毒载荷再激活的保护相关

获取原文
获取原文并翻译 | 示例
           

摘要

Immune correlates of protection against human cytomegalovirus (HCMV) infection are still debated. This study aimed to investigate which arm of the immune response plays a major role in protection against HCMV infection in kidney transplant recipients (n?=?40) and heart transplant recipients (n?=?12). Overall, patients were divided into 2 groups: one including 37 patients with low viral load (LVL), and the other including 15 patients with high viral load (HVL). All LVL patients resolved the infection spontaneously, whereas HVL patients were all treated with one or more courses of antivirals. In HVL patients, viral DNAemia, which was more than 100 times higher than LVL, appeared and peaked at significantly earlier times, but disappeared much later than in LVL patients. During a 1‐year follow‐up, all LVL patients had levels of HCMV‐specific CD4 + (and CD8 + ) T cells significantly higher than HVL patients. On the contrary, titers of neutralizing antibodies and enzyme‐linked immunosorbent assay‐IgG antibodies to gB, gHgLgO, and pentamer gHgLpUL128L were overlapping in the 2 patient groups. In conclusion, while a valid HCMV‐specific T‐cell response was detected in more than 90% of LVL patients, 90% of HVL patients lacked an adequate T‐cell response. Antibody responses did not appear to be associated directly or indirectly with protection.
机译:仍然讨论了对人巨细胞病毒(HCMV)感染的免疫相关性。本研究旨在调查免疫反应的哪个手臂在肾移植受者(n?= 40)和心脏移植接受者(n?= 12)中的HCMV感染保护中的主要作用。总体而言,患者分为2组:其中包括37例病毒载荷(LVL),另一个患者,包括15名高病毒载荷(HVL)。所有LVL患者都自发地解决了感染,而HVL患者均用一个或多个抗病毒课程治疗。在HVL患者中,病毒DNAEMIA比LV1高出100倍,显着提前达到峰值,但在LVL患者中消失了很高。在1年的随访中,所有LVL患者的HCMV特异性CD4 +(和CD8 +)T细胞水平明显高于HVL患者。相反,将抗体和酶联免疫吸附的免疫吸附的免疫吸附测定-IgG抗体与GB,GHGLGO和五聚体GHGLPUL128L中和中和抗体和酶联免疫吸附的滴度滴定在2个患者基团中重叠。总之,在超过90%的LVL患者中检测到有效的HCMV特异性T细胞反应,而GT; 90%的HVL患者缺乏足够的T细胞反应。抗体反应似乎没有直接或间接相关的保护。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号